MedTrace Logo

Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer

NCT05049408 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1160

Last updated 2021-09-28

No results posted yet for this study

Summary

The study is designed to measure salivary matrix metalloproteinase-1 (MMP-1) using the enzyme-linked immunosorbent assay (ELISA) we developed previously in patients with oral potentially malignant disorders (OPMD), oral squamous cell carcinoma (OSCC), and healthy participants. The purpose of this study is to evaluate the potential of the newly developed salivary MMP-1 ELISA as an adjunctive tool to aid in diagnosis of OSCC.

Conditions

  • Oral Squamous Cell Carcinoma

Interventions

DIAGNOSTIC_TEST

MMP-1 Enzyme Linked Immunosorbent assay (ELISA)

The MMP-1 ELISA is to measure salivary MMP-1 levels of participants

Sponsors & Collaborators

  • S&T Biomed Co., Ltd.

    lead INDUSTRY

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-02-17
Primary Completion
2016-12-07
Completion
2016-12-07

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05049408 on ClinicalTrials.gov